Janus Henderson Group plc 13D and 13G filings for Dyne Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 12:22 pm Purchase |
2024-12-31 | 13G | Dyne Therapeutics, Inc. DYN |
JANUS HENDERSON GROUP PLC JHG |
7,379,309 7.300% |
566,146 (+8.31%) |
Filing |
| 2024-11-14 10:28 am Purchase |
2024-09-30 | 13G | Dyne Therapeutics, Inc. DYN |
JANUS HENDERSON GROUP PLC JHG |
6,813,163 6.800% |
6,813,163 (New Position) |
Filing |